SCHEMBL21788045

SCHEMBL21788045

COC(=O)c1cc(C(N)=O)oc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.44
GAA P10253 4/20 0.41
NQO2 P16083 4/20 0.40
ALDH1A1 P00352 7/20 0.39
KDM4E B2RXH2 6/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 4/20 0.39
HPGD P15428 3/20 0.39
HSD17B10 Q99714 3/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
GLA P06280 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
ATM Q13315 1/20 0.38
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CFTR P13569 1/20 0.37
NPC1 O15118 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21776796 0.84 DAO (0.53) ABL1GAAALDH1A1KDM4EPOLB
SCHEMBL21776750 0.81 ABL1 (0.39) ABL1GAAALDH1A1KDM4EPOLB
SCHEMBL19506014 0.73 ALDH1A1 (0.51) ABL1GAAALDH1A1TSHRLMNA
SCHEMBL21787713 0.72 CA12 (0.41) ABL1GAAALDH1A1KDM4EPOLB
SCHEMBL21787787 0.72 ALDH1A1 (0.47) ABL1GAAALDH1A1KDM4EPOLB
SCHEMBL19506015 0.71 CA1 (0.39) ABL1GAAALDH1A1KDM4EHPGD
SCHEMBL31215708 0.71 KDM4E (0.49) ABL1GAANQO2ALDH1A1KDM4E
SCHEMBL31215545 0.71 NPC1 (0.42) GAAALDH1A1KDM4EPOLBMAPT
SCHEMBL19258586 0.68 HTT (0.58) GAAALDH1A1KDM4EPOLBMAPT
SCHEMBL31215837 0.68 KDM4E (0.37) GAAALDH1A1KDM4EPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020043821-A1 FURAN DERIVATIVES AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2020-03-05 WO disclosed